Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal rsv vaccine

HIGHLIGHTS

• who: Mucosal RSV Vaccine and collaborators from the (UMR1313), French National Institute for Agricultural Research, Jouy-en-Josas, FranceEditor: Ralph Tripp, University of Georgia, United States of America have published the research: Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine, in the Journal: (JOURNAL) of May/24,/2012
• what: The authors investigated the safety and efficacy of ring-nanostructures formed by the recombinant nucleoprotein N of hRSV (NSRS) as a candidate against in BALB/c neonates which are highly sensitive to immunopathological Th2 imprinting.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.